Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Jesus San, Miguel"'
Autor:
Francesca Di Giuseppe, Claudia Vitolo, Christopher Barnard, Giorgio Libertá, Pedro Maciel, Jesus San-Miguel-Ayanz, Sebastien Villaume, Fredrik Wetterhall
Publikováno v:
Scientific Data, Vol 11, Iss 1, Pp 1-10 (2024)
Abstract The European Centre for Medium range weather forecast (ECMWF) on behalf of the Copernicus Emergency Management Service (CEMS) has recently widened the fire danger data offering in the Climate Data Store (CDS) to include a set of fire danger
Externí odkaz:
https://doaj.org/article/8375430e28cb4b73b2638d248ebffc13
Autor:
Paul G. Richardson, Aurore Perrot, Jesus San Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A. Dimopoulos, Shang-Yi Huang, Jiri Minarik, Michele Cavo, H. Miles Prince, Sandrine Macé, Rick Zhang, Franck Dubin, Mony Chenda Morisse, Kenneth C. Anderson
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The primary and pre-specified updated analyses of ICARIA-MM (NCT02990338) demonstrated improved progression-free survival and a benefit in overall survival (OS) was reported with the addition of isatuximab, an anti-CD38 monoclonal antibody, to pomali
Externí odkaz:
https://doaj.org/article/2cdeb822507640969679ff3be53cc866
Autor:
Pablo Botella-Asunción, Eva M. Rivero-Buceta, Carla Vidaurre-Agut, Raquel Lama, Magalí Rey-Campos, Alejandro Moreno, Laura Mendoza, Patricia Mingo-Casas, Estela Escribano-Romero, Alfonso Gutierrez-Adan, Juan Carlos Saiz, Cristian Smerdou, Gloria Gonzalez, Felipe Prosper, Josepmaría Argemí, Jesus San Miguel, Pedro J. Sanchez-Cordón, Antonio Figueras, Jose Manuel Quesada-Gomez, Beatriz Novoa, María Montoya, Miguel A. Martín-Acebes, Antonio Pineda-Lucena, Jose María Benlloch
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 169, Iss , Pp 115882- (2023)
An archetypal anti-inflammatory compound against cytokine storm would inhibit it without suppressing the innate immune response. AG5, an anti-inflammatory compound, has been developed as synthetic derivative of andrographolide, which is highly absorb
Externí odkaz:
https://doaj.org/article/a903dd016e1c46c185be5fbc8b65e725
Autor:
Enrique M. Ocio, Sara Bringhen, Joaquin Martinez-Lopez, Jesus San-Miguel, Stefania Oliva, Paula Rodriguez-Otero, Nadia Le Roux, Yvonne Dong, Severine Doroumian, Sandrine Macé, Maria-Victoria Mateos
Publikováno v:
HemaSphere, Vol 7, Iss 2, p e829 (2023)
Externí odkaz:
https://doaj.org/article/4f2b10bc60bc4c0fa2b3b7b2010e704c
Autor:
Emilio Chuvieco, Marta Yebra, Simone Martino, Kirsten Thonicke, Marta Gómez-Giménez, Jesus San-Miguel, Duarte Oom, Ramona Velea, Florent Mouillot, Juan R. Molina, Ana I. Miranda, Diogo Lopes, Michele Salis, Marin Bugaric, Mikhail Sofiev, Evgeny Kadantsev, Ioannis Z. Gitas, Dimitris Stavrakoudis, George Eftychidis, Avi Bar-Massada, Alex Neidermeier, Valerio Pampanoni, M. Lucrecia Pettinari, Fatima Arrogante-Funes, Clara Ochoa, Bruno Moreira, Domingos Viegas
Publikováno v:
Fire, Vol 6, Iss 5, p 215 (2023)
This paper presents a review of concepts related to wildfire risk assessment, including the determination of fire ignition and propagation (fire danger), the extent to which fire may spatially overlap with valued assets (exposure), and the potential
Externí odkaz:
https://doaj.org/article/234a5e7a12f6420dad38473dafa60246
Autor:
Stefan Knop, Maria-Victoria Mateos, Meletios A. Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Ganna Usenko, Ludek Pour, Mark Cook, Sebastian Grosicki, Andre Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Losava, Tomoaki Fujisaki, Mamta Garg, Jianping Wang, Susan Wroblewski, Anupa Kudva, Katharine S. Gries, John Fastenau, Jesus San-Miguel, Michele Cavo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background In the phase III ALCYONE trial, daratumumab plus bortezomib/melphalan/prednisone (D-VMP) significantly improved overall response rate and progression-free status compared with VMP alone in transplant-ineligible patients with newly
Externí odkaz:
https://doaj.org/article/b999c61f13244d59a68cdf925de95954
Autor:
Giovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesus San-Miguel, Giampaolo Merlini
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Abstract Light chain (AL) amyloidosis is caused by a small B-cell clone producing light chains that form amyloid deposits and cause organ dysfunction. Chemotherapy aims at suppressing the production of the toxic light chain (LC) and restore organ fun
Externí odkaz:
https://doaj.org/article/1af0c29e396946d49b7a958dc256ed9f
Autor:
Jesus San-Miguel
Publikováno v:
HemaSphere, Vol 6, Pp 3-4 (2022)
Externí odkaz:
https://doaj.org/article/7d79010e0a08493b80d2ff6b15ad1282
Autor:
Pellegrino Musto, Monika Engelhardt, Jo Caers, Niccolo’ Bolli, Martin Kaiser, Niels van de Donk, Evangelos Terpos, Annemiek Broijl, Carlos Fernández de Larrea, Francesca Gay, Hartmut Goldschmidt, Roman Hajek, Annette Juul Vangsted, Elena Zamagni, Sonja Zweegman, Michele Cavo, Meletios Dimopoulos, Hermann Einsele, Heinz Ludwig, Giovanni Barosi, Mario Boccadoro, Maria-Victoria Mateos, Pieter Sonneveld, Jesus San Miguel
Publikováno v:
Haematologica, Vol 106, Iss 11 (2021)
According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10% and
Externí odkaz:
https://doaj.org/article/cf3a4b9480b34ab1a0ab540a0e81ad4b
Autor:
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W. C. J. van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hajek, Philippe Moreau, Hermann Einsele, Jesus San-Miguel, Mario Boccadoro, Meletios A. Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Publikováno v:
Leukemia. 37(6):1175-1185
In the post-pandemic COVID-19 period, human activities have returned to normal and COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an increased risk for breakthrough infections and severe COVID-19 outcomes, inclu